Weekly Recap | Editas Medicine -16.41%, consensus target above spotWeekly Review·1 day ago, 08:10 AMEDIT+1.89%
Weekly Recap | Caris Life Sciences -2.91%, most brokers rate it buyWeekly Review·1 day ago, 07:49 AMCAI+1.25%
Weekly Recap | Twist Bioscience +2%, consensus target below spotWeekly Review·1 day ago, 07:00 AMTWST+0.29%
Weekly Recap | Sellas Life Sciences -16.7%, Friday's heavy-volume slideWeekly Review·1 day ago, 06:47 AMSLS-14.42%
Weekly Recap | Revolution Medicines -2.98%, consensus target above spotWeekly Review·1 day ago, 06:40 AMRVMD+0.21%
Weekly Recap | Regeneron Pharma -5.59%, class action deadline passesWeekly Review·1 day ago, 06:39 AMREGN-1.48%
Weekly Recap | Larimar Therapeutics +2.35%, most brokers rate it buyWeekly Review·1 day ago, 06:12 AMLRMR+1.82%
Weekly Recap | SPDR S&P Biotech -4.65%, most brokers rate it buyWeekly Review·1 day ago, 05:07 AMXBI-0.40%LABD+1.23%
The Nasdaq Biotechnology Index fell by more than 1%. Among the constituent stocks, Lyell Immunopharma dropped 11.28%, Vor Biopharma fell 8.16%, Alumis decreased 6.99%, and Oruka Therapeutics declined 7.93%. Meanwhile, Coherus BioSciences rose 6.34%, Pyxis Oncology increased 8.02%, Ultragenyx Pharmaceutical gained 13.59%, and Jyong Biotech surged 43.38%Wallstreetcn·Dec 30, 2025 at 07:31 PMLYEL-1.97%PYXS-1.83%
The Nasdaq Biotechnology Index fell by more than 2%. Among them, Sutro Biopharma dropped 12.98%, Kyverna Therapeutics fell 10.95%, GRAIL decreased 10.01%, and Pyxis Oncology declined 9.34%. Ironwood Pharma rose 4.44%, Arrowhead Pharmaceuticals increased 4.63%, Neumora Therapeutics grew 6.92%, and Q32 Bio surged 92.69%Wallstreetcn·Dec 1, 2025 at 05:39 PMIRWD+2.77%STRO-5.44%
The Nasdaq Biotechnology Index fell by 2.3%. Among the constituent stocks, uniQure NV had the largest decline, reaching 55.76%; Tscan Therapeutics fell by 42.27%; Alvotech dropped by 30.72%; Neurogene decreased by 16.87%. On the other hand, Hutchison China MediTech (HCM) rose by 3.10%, Indivior increased by 4.29%, Acrivon Therapeutics went up by 8.79%, Pyxis Oncology climbed by 11.97%, and Terns Pharmaceuticals surged by 81.84%Wallstreetcn·Nov 3, 2025 at 04:04 PMPYXS-1.83%TERN0.00%
